- Home
- FTFT vs INM Comparison
FTFT vs INM Comparison
Compare FTFT & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- INM
- Stock Information
- Founded
- FTFT N/A
- INM 1981
- Country
- FTFT United States
- INM Canada
- Employees
- FTFT N/A
- INM N/A
- Industry
- FTFT Business Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- INM Health Care
- Exchange
- FTFT Nasdaq
- INM Nasdaq
- Market Cap
- FTFT 3.9M
- INM 3.2M
- IPO Year
- FTFT N/A
- INM N/A
- Fundamental
- Price
- FTFT $1.54
- INM $3.00
- Analyst Decision
- FTFT
- INM
- Analyst Count
- FTFT 0
- INM 0
- Target Price
- FTFT N/A
- INM N/A
- AVG Volume (30 Days)
- FTFT 82.2K
- INM 56.6K
- Earning Date
- FTFT 04-15-2025
- INM 05-13-2025
- Dividend Yield
- FTFT N/A
- INM N/A
- EPS Growth
- FTFT N/A
- INM N/A
- EPS
- FTFT N/A
- INM N/A
- Revenue
- FTFT $2,158,125.00
- INM $4,832,013.00
- Revenue This Year
- FTFT N/A
- INM N/A
- Revenue Next Year
- FTFT N/A
- INM N/A
- P/E Ratio
- FTFT N/A
- INM N/A
- Revenue Growth
- FTFT N/A
- INM N/A
- 52 Week Low
- FTFT $1.15
- INM $1.72
- 52 Week High
- FTFT $9.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- FTFT 44.93
- INM 62.76
- Support Level
- FTFT $1.28
- INM $2.56
- Resistance Level
- FTFT $1.49
- INM $3.05
- Average True Range (ATR)
- FTFT 0.16
- INM 0.27
- MACD
- FTFT 0.05
- INM 0.09
- Stochastic Oscillator
- FTFT 75.02
- INM 92.98
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.